Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxidex in Sjogren's Syndrome
NCT00631358Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in Sjogren's syndrome, sponsored by Alcon Inc.. Started Feb 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT00631358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631358.